Anemia in Ageing Population: A Study of Prevalence and Causes by Priyamalini, D
DISSERTATION
on
ANEMIA IN AGEING POPULATION – A STUDY OF
PREVALENCE AND CAUSES
Submitted in partial fulfillment of
MD DEGREE EXAMINATION
BRANCH-XVI GERIATRIC MEDICINE
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY
CHENNAI
MADRAS MEDICAL COLLEGE
CHENNAI – 600003
APRIL 2013
CERTIFICATE
This is to certify that the dissertation titled “ANEMIA OF
AGEING POPULATION –A STUDY OF PREVALENCE AND
CAUSES” a bonafide work done by Dr. D. PRIYAMALINI,
Post Graduate Student, Department of Geriatric Medicine, Madras
Medical College, Chennai – 600003, in partial fulfillment of the
university rules and regulations for the award of MD DEGREE in
GERIATRIC MEDICINE BRANCH-XVI, under our guidance and
supervision, during the academic period from April 2010 to April 2013.
Prof. B. KRISHNASWAMY, MD,
Professor and Head,
Department of Geriatric Medicine,
MMC and RGGGH,
Chennai – 600003.
Prof. V. KANAGASABAI, MD,
Dean,
MMC and RGGGH,
Chennai – 600003.
DECLARATION
 I solemnly declare that the dissertation titled “ ANEMIA IN
AGEING POPULATION – A STUDY OF PREVALENCE AND
CAUSES ” was  done  by  me  at  Madras  Medical  College  ,  Chennai  -03
during the period June 2012  to December 2012 under the guidance of
Prof. B. KRISHNASWAMY, MD,  to be submitted to The Tamil Nadu
Dr. M.G.R. Medical University towards the partial fulfillment of
requirements for the award of MD DEGREE in GERIATRIC
MEDICINE BRANCH-XVI.
Place : Chennai
Date  :
Dr. D.PRIYAMALINI,
MD GERIATRIC MEDICINE,
Post Graduate Student,
Department of Geriatric Medicine,
Madras Medical College,
Chennai – 600003.
ACKNOWLEDGEMENT
I thank Prof. V. KANAGASABAI, MD, Dean, Madras Medical
College, for having permitted me to conduct the study and use the
hospital resources in the study.
I express my heartfelt gratitude to Prof. B.KRISHNASWAMY,
MD, Professor and Head, Department of Geriatric medicine, for his
inspiration, advice and guidance in making this work complete.
I am extremely thankful to Prof. S.SIVAKUMAR, MD, Associate
professor, Department of Geriatric medicine for guiding me during the
period of study.
I am extremely thankful to Dr. G.USHA, MD, Assistant Professor,
Dr. S.DEEPA, MD, Assistant professor, Dr. K.UMA KALYANI, MD,
Assistant professor, and Dr. M SENTHIL KUMAR, MD, Assistant
Professor, Department of Geriatric medicine, for guiding me
academically and professionally during the period of study.
I also thank all the postgraduate students and paramedical staff for
their cooperation which enormously helped me in the study. I am also
indebted to thank all the patients and their caring relatives. Without their
humble cooperation, this study would not have been possible.
TABLE OF CONTENTS
1.  INTRODUCTION 1
2.  AIMS OF THE STUDY 4
3.  REVIEW OF LITERATURE 5
4.  MATERIALS AND METHODS 46
5.  RESULTS AND ANALYSIS 51
6.  DISCUSSION 69
7.  CONCLUSION 79
8.  BIBLIOGRAPHY
9.  ANNEXURES
PROFORMA
CONSENT FORM
ETHICAL COMMITTEE APPROVAL FORM
TURNITIN DIGITAL RECEIPT
ANTI-PLAGIARISM REPORT
MASTER CHART
1INTRODUCTION
 Population ageing is occurring worldwide and it is more so in
developing countries like India.  There is a double burden with the ageing
population on one end and the existing older persons are getting older as
well. Keeping this demographic reality, characterization of health
conditions that have impact on the functional as well as the survival in
older age population is necessary.
Anemia is one of the commonest disease that has adverse outcome
in older population including hospitalisation, disability and mortality.
Since anemia is a multi-factorial condition, it is difficult to establish
whether anemia is a marker of disease burden or a mediator in casual
pathway leading to adverse impacts. Varying degrees of anemia may be
present in the elderly patient. It may be common, but it should not be
accepted as normal aging.
Poorer outcomes associated with anemic elders, and the mortality
rate is increased in these patients. As the geriatric population grows, the
incidence of anemia and its complications in this population will become
a significant healthcare burden.
2Geriatric patients may have psychological, sociological, and
physical changes resulting from aging that complicate treatment. Careful
oversight will help to prevent redundant tests or treatments and thus
reduces polypharmacy.
In 2000, global ageing population was 600 million and this tends to
double in 2025 and triple by 2050. A recent study on Prevalence of
Anemia by National Health And Nutrition Examination Survey
(NHANES lll) showed the following indices:
? Older men – 11% prevalence
? Older women – 10.2%
? Overall community dwelling (> 65 years) – 10.6%
As age progresses prevalence of anemia steadily increase and found
to be highest in age group > 85 years. Significant differences were also
perceived with respect to race and ethnicity and both sexes.
? 65-75 years:  women > men
? 75-85 years: men > women
? >85 years: men > women
3Prevalence was the lowest in non Hispanic whites and in the Non-
Hispanic blacks. Identifying anemia as an important aspect of
comprehensive geriatric assessment is essential. Identifying the type of
anemia goes a long way in improving the overall outcome of the elderly
and their quality of life.
4AIM OF STUDY
1. To assess the different types of anemia in elderly patients.
2. To Assess the nutritional status of the patient and to correlate with
the type Anemia
3. To assess anemia of chronic illness
4. To assess the prevalence of Myelo Dysplastic Syndrome in Indian
elderly.
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DEMOGRAPHY
Prevalence of anemia in elderly according to western reports is
8 – 44%. Significant percentage of  anemia  occurs in  Nursing home
residents , hospital in-patients followed by community dwellers.(1) (7) (23)
Elderly population in India is rising exponentially. The elder
population which was around 1 crore in 1901 has become 8 crore in 2010.
According to 2010 census their population is about 8% percentage of the
total population in India. The Indian aged population is the second largest
in the world.
Most of the elderly are dependent both physically and financially.
The health status of the elder population makes them more dependent.
Older people present with atypical symptoms for common ailments.(3) (4)
Hence the diagnosis becomes difficult and delayed. This sets in multiple
other co- morbidities leading to functional decline.
PATHOGENESIS OF ANEMIA IN ELDERLY
Debate is still on whether anemia in elderly has a specific
underlying cause as in other age groups or is purely a decline of marrow
function- a process seen in ageing. (11)
6Hemopoietic changes in marrow due to ageing shows decreased
number of committed stem cells and increase in fat.(18) Inaddition to these
changes, anemia is found to be a result of blunted response to
hemopoietic stress such as malnutrition, chronic inflammatory disease,
chronic kidney disease and   iron deficiency.
Nutritional deficiency is reported to be not common in elderly in
western countries as in young, mainly because of iron stores which have
cumulatively built up in tissues. Predictors of nutritional status like serum
albumin, transferrin and pre-albumin were also found to be good
predictors of anemia.
Alteration in hemopoietic function in ageing was found to be
similar to protein energy malnutrition. A low BMI is also associated with
high risk of mortality in ageing.
BIOLOGY OF HEMOTOPOIESIS
Hematopoietic system arises from a small pool of hematopoietic
stem cells which either differentiates into mature leukocytes, erythrocytes
or platelets or self renews itself.(18) HSC’s differentiation occurs through
committed progenitor and precursors. Haematopoiesis is regulated by
complex interactions between HSC’s, stromal micro environment and
hematopoietic growth factors. Hence a strict balance is needed to
7maintain self- renewal differentiation, maturation and cell loss. In the
bone marrow, the first morphologically recognizable erythroid precursor
is the pronormoblast. This cell can undergo 4–5 cell divisions that result
in the production of 16–32 mature red cells. With increased EPO
production, or the administration of EPO as a drug, early progenitor cell
numbers are amplified and, in turn, give rise to increased numbers of
erythrocytes. The regulation of EPO production itself is linked to O2
availability.
In mammals, O2 is transported to tissues bound to the hemoglobin
contained within circulating red cells. The mature red cell is 8 microns in
diameter, anucleate, discoid in shape, and extremely pliable in order to
traverse the microcirculation successfully; its membrane integrity is
maintained by the intracellular generation of ATP. Normal red cell
8production results in the daily replacement of 0.8–1% of all circulating
red cells in the body, since the average red cell lives 100–120 days. The
organ responsible for red cell production is called the erythron. The
erythron is a dynamic organ made up of a rapidly proliferating pool of
marrow erythroid precursor cells and a large mass of mature circulating
red blood cells. The size of the red cell mass reflects the balance of red
cell production and destruction. The physiologic basis of red cell
production and destruction provides an understanding of the mechanisms
that can lead to anemia.
EFFECTS OF AGEING ON HEMATOPOIESIS AND BONE
MARROW FUNCTION
? In ageing replicative capacity of hemopoietic stem cells
decreases and the ability of hemopoietic system to respond to
stress decreases.(11)
? The RBC survival is unchanged and the plasma iron turn over
remains unchanged. Red cell mass is normal and there is no
obvious change in basal hemopoiesis with ageing.
The suboptimal response of hemopoietic system in stimulus driven
situation and failure to maintain hemostasis is characteristic of ageing
hemopoietic system. This blunted response is due to multiple factors like
9age related defects in marrow progenitor cells, changes in marrow micro
environment, decreased production of regulatory growth factors.
Predictors of nutritional status like serum albumin, serum
transferrin and pre- albumin were also found to be good predictors of
anaemia.  Since these parameters determine the status of the elderly their
measure is important in any case of nutritional survey.
An alteration of hemopoietic function in ageing is similar to protein
energy malnutrition. A low BMI is also associated with high risk of
mortality in ageing.
EFFECTS OF ANEMIA IN ELDERLY
Recent investigations have shown that anemia accounts for
significant morbidity and mortality in elderly patients and can lead
to cardiovascular and neurological manifestations like congestive
cardiac failure, impaired cognitive functions, falls and functional
impairment.(13) (37)
Anemia in geriatric population has been associated with increased
frailty, decreased cognitive function, poor exercise performance,
decreased mobility, increased chances for dementia, increased risk of falls
and increased rates of depression.(31)(36)(38)(40)
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Studies have shown that presence of both anemia and other co-
morbidities are associated with increased risk of adverse
outcomes.(15)(21)(30)
Anemia has a major impact on cardio vascular system in elderly
and both these risk factors leads to frailty.(28) A hospital based study
showed an association between anemia and impairment of executive
function.(39)
Mortality:
 Anemia which primarily constitute the WHO defined anemia, is an
independent risk factor for 5 year all-cause mortality. Mortality risk also
increases with increase in severity of anemia.(13)(25) Also the interaction of
anemia with other co-morbidities including chronic kidney disease, left
ventricular hypertrophy and chronic vascular disease increases the
mortality risk in older patients.
Decline in physical function:
Anemia is related to decline in physical function as well as physical
disability.(15)(25) Low normal haemoglobin levels were associated with
increased likelihood of morbidity and disability. Anemia is associated
with reduced aerobic capacity, increased fatigueness and difficulty in
carrying out basic activities of daily living.(35)
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Frailty status:
Frailty is defined as presence of 3 out of the 5 manifestations,
including shrinkage, slowness, weakness, exhaustion and low energy
expenditure. Anemia is one risk factor causative of frailty.(35)
WHO - Definition of anemia
Anemia is defined by WHO criteria which was established in 1986,
as Hemoglobin concentration of <13g/dl in men and <12g/dl in women.
The difference in values of Hemoglobin in gender is because of
differences in the distribution of Hemoglobin in older men and women.
Conceptually anemia is a clinical syndrome caused by reduced mass of
circulatory RBC.
Practically anemia is defined as decreased level of the following
parameters
? Concentration of Hb in the whole blood.
? Hematocrit(Hct).
? Number of RBCs in standardised volume of whole blood.
Hemoglobin is expressed in g/dl, Hematocrit as % and RBC count
as number of RBCs in million per micro-litre.
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CLASSIFICATION OF ANEMIA
Morphological classification of anemia
On the basis of MCV, MCH, MCHC three main types of anemia
are recognized.
1. Hypochromic microcytic anemia:
a. The MCV is subnormal <80 fl
b. MCH< 27 pg
c. MCHC< 30g/dl
Most important examples are iron deficiency in which there is
inadequate iron for the formation of the heme component of
haemoglobin and thalassemia, in which the formation of the
globin component of the haemoglobin is defective.
2. Macrocytic anemia
a. MCV is above >96 fl
b. Megaloblastosis of bone marrow
c. Due to B12 or folatedeficiency
3. Normochromic normocytic anemia:
a. MCV, MCH, MCHC are within normal limits
b. Loss of substantial amount of blood
13
c. Haemolysis
d. Bone marrow failure
e. Chronic renal failure
f. Chronic inflammation or infection
Basic Pathophysiological Categories of Anemia
A. Impaired red cell production
a. Decreased nutrient supply
i. Iron deficiency
ii. Vitamin B12 deficiency
iii. Folic acid deficiency
iv. Protein calorie malnutrition
b. Decreased erythropoetic activity
i. Infection
ii. Connective tissue disorders
iii. Inflammatory disorders
iv. Disseminated malignancy
v. Associated with renal failure
vi. Aplastic anemia
B. Anemia due to replacement of normal bone marrow
a) Leukemia
b) Lymphoma
14
Anemia in
Elderly
Nutritional
Anemia
Iron
Deficiency
Vitamin
B12
Deficiency
Folate
Deficiency
Anemia of
Chronic
Disease
Anemia of
Renal
Disease
Unexplaine
d Anemia
c) Myelodysplastic abnormalities
d) Myeloproliferative disorders
e) Myeloma
Clinical Classification of Anemia in elderly
SYMPTOMS AND SIGNS OF ANEMIA
1. Easy fatigability
2. Irritability
3. Weakness
4. Breathlessness
5. Pale lips and skin
6. Brittle concave nails
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7. Frontal headache
8. Sore tongue
9. Orthostatic hypotension
10. Tachycardia
INVESTIGATIONS DONE FOR A CASE OF ANEMIA
Tests that are commonly used in the preliminary assessment of
anemia includes complete assessment of blood count and a number a key
parameters including RBC count, WBC count, Hb concentration,
hematocrit, mean corpuscular hemoglobin concentration, RDW, platelet
count. Other additional tests include serum iron, serum ferritin, transferrin
saturation are done for iron deficiency anemia.
To assess Vitamin B12 deficiency test such as serum Vitamin B12,
serum methylmalonic acid, serum homocysteine are done. Measurement
of methylmalonic acid and total homocysteine is a more sensitive test to
assess Vitamin B12 deficiency because these levels elevate before serum
Vitamin B12 falls. Tests to assess Folate deficiency include serum Folate
and RBC Folate. GFR is calculated to assess renal function. For
evaluation of hemolysis serum lactate dehydrogenase, indirect bilirubin
concentration, serum haptoglobin concentration is measured. To evaluate
occult GI bleeding, fecal occult blood detection is done and endoscopy of
16
the entire GI tract is done to rule out malignancy. Bone marrow is
evaluated by bone marrow biopsy and trephine biopsy. For selected
endocrine disorders concerned hormone status is seen. Liver function
tests are also done.
Additional measurements include serum erythropoietin, pro
inflammatory markers like C reactive protein, interleukin 6, TNF- alpha.
Hepcidin is important modulator of iron mechanism which play an
important role in the pathogenesis of ACI. Hepcidin will prove to be
useful in clinical decision making.
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Microcytic Anemia
Iron Stores (Sr.
Ferritin)
Normal/
Increased
Signs of Inflammation/CRP
Inflammation
Anemia of Chronic
Disease (ACD)
No Inflammation
Thalassemia
Decreased
Sr. Iron , TIBC
Iron Deficiency
Anemia
APPROACH TO MICROCYTIC ANEMIA
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APPROACH TO MACROCYTIC ANEMIA
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APPROACH TO NORMOCYTIC ANEMIA
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INVESTIGATIONS
HEMOGLOBIN
Methods for Hb estimation:
1. Sahli’s method- observer error common.
2. Artificial neural network approach (ANN).
3. Drabkin method- more reliable.
4. Acid hematin-automated counter. Useful in estimation of Hb in
large batches, in tertiary laboratory.
5. Portable Hb Photometer ( Hemocue )
Prevalence of anemia was higher when indirect method was used
compared to direct method or the Hemocue .  This may have been caused
by the blood on the filter paper very incompletely dissolved, although the
technician soaked the paper in Drabkin’s solution.
Larger differences in the estimated prevalence of anemia
determined by two different methods mean a methodological difference
should be examined critically before the results of different surveys are
compared.
21
Hemoglobin concentration assessed in capillary blood was slightly
lower than that assessed by venous blood. This is because the capillary
blood vessel is small, the red cell volume of the capillary blood is 1-3 %
lower than the venous blood.
Reticulocyte count
Reticulocyte count is one of the basic investigations done in
anemia. It is a measure of immature red blood cells without a cell nucleus.
It is a good predictor of bone marrow activity. Reticulocytes develop and
mature in the red bone marrow and then circulate in blood stream for a
day and then mature into mature RBC. On Romanowsy stain they appear
slightly bluer and  slightly larger with increased MCV.
? Normal range : 0.5-1.5 %
? Reticulocyte production index is an absolute measure of
marrow function.
? Reticulocyte index > 2 % - adequate response
? Reticulocyte index < 2 % - hypoproliferation of bone
marrow
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RETICULOCYTES: Methylene blue stain demonstrates residual RNA in newly
made red cells
This is calculated as
Reticulocyte production index / absolute reticulocyte count = % of
Reticulocyte   × patient Hemotocrit / Normal Hemotocrit
High reticulocyte occur in:
? Hemolytic Anemia
? Acute or chronic hemorrhage
Low reticulocyte  occur in:
? ACD
? Nutritional anemia
? Bone marrow malignancies
? Aplastic anemia
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PERIPHERAL SMEAR
Peripheral smear is an essential investigation in all cases of anemia.
After diagnosis of anemia is established with Hb levels and other indices,
peripheral smear is the next important investigation to be done. If found
grossly abnormal bone marrow aspiration or biopsy becomes very
essential.
USES:
1. To Classify different types of Anemia
2. To investigate hemotological problems
3. To look for parasites like Malaria/Filaria
Sterile blood drop is placed on one end of the slide and with a
spreader slide, the blood is dispersed over the length of the slide. Slide is
then air dried and fixed with methanol. Romanowsky/ Wright’s/ Geimsa
staining is performed. Wright Geimsa stain is commonly used.
The cells in the monolayer film is counted and differentiated. Total
number of RBC, WBC and platelets are counted. Abnormal red cell
morphology or red cell inclusions are assessed. White cell abnormalities
and platelets morphology are also assessed. Presence of blast cells,
normoblasts were also noted.
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Sr.FERRITIN
Sr. ferritin reflects the total body iron stores. Ferritin is globular
protein complex consisting of 24 protein sub units. It exists in soluble and
non toxic form. Ferritin is an acute phase protein heme increased in
chronic inflammatory conditions.
Normal ferritin levels:
? Men – 20 to 300 ng/dl
? Women- 15 to 150 ng/dl
IMPLICATION OF  SERUM. FERRITN
? Iron deficiency anemia:  Sr. ferritin <10 ng/dl
? Anemia of chronic diseases:  Sr. ferritin >60 ng/dl
? Moderate increase in Sr.ferritin occurs in inflammatory
conditions like chronic renal diseases, Rheumatoid arthritis
and malignancies.
? High serum ferritin values occurs in ESRD and Hepatitis.
? Low serum ferritin:
? Hypothyroidism
? Vitamin C deficiency
? Celiac disease
? Vegetarian
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Ferritin is also used as a marker for iron overload states like
hemosiderosis, hemochromatosis, etc. High serum ferritin is risk factor
for Myocardial Infarction in men.
Iron is stored within the cells complexed protein as ferritin. Under
normal conditions serum ferritin correlates well with total body iron
stores. Hence serum ferritin is used to estimate iron stores. Adult males
have values around 100 µg/dl compared to females averaging 30µg/dl.
Serum ferritin level falls < 15µg/dl as the iron stores depletes with age.
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METHODS FOR FERRITIN ESTIMATION
1. ELISA- method for quantitative determination of ferritin in serum
or plasma. Sensitivity- 92.4%, specificity- 94.6%
2. Radio immunoassay
ERYTHROPOIETIN
EPO is an important glycoprotein that is secreted from the kidney
and small proportion in the liver hepatocytes. EPO level increases the
production of erythropoietic progenitor cells to a lesser extent and mainly
decreases the apoptosis of these progenitor cells. Reticulocyte is a red
blood cell which has lost its nucleus retaining its polyribosomal nuclear
pattern. These reticulocytes lose their ribosomal pattern in 1-4 days and
become red blood cells. Impaired EPO levels is considered reason for
anemia in elderly. The EPO level  in elderly shows a lower slope of rise
suggesting failure of compensatory increase. Supporting this hypothesis
administration of EPO and iron shows improvement in these patients.
EPO is responsible for day to day RBC production and the ambient
normal level is measured by ferritin immunoassay. The normal level is
between 10- 25 u/l. When EPO is stimulated, red cell production increase
four to five fold within a week period. The functional capacity of
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erythropoietin requires normal renal parameters, good functional bone
marrow, and substrates for Hb synthesis.
When the Hb decrease to 12.8 g/dl serum erythropoietin levels
increase longitudinally. As age progressed the level of erythropoietin
needed to sustain normal Hb level appear to increase.
BONE MARROW ASPIRATION
Aspiration of the bone is done via a wide bore short beveled needle
fitted with a stillete inserted into the bone marrow cavity. There is
adjustable guard to prevent over penetration. This Diagnostic test, though
very useful is not done in all anemic patients, as it is an invasive
procedure.
  The test is carried out when establishing the diagnosis is a must
and in low volumes of Hemoglobin and in suspicion of hematological
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malignancies. Advantage of this procedure is that the films that are
prepared are examined immediately.
Commonest site used are
1. Iliac crest
2. Body of sternum
Local anesthesia is infiltrated into the periosteum of the bone, then
the needle is inserted into the bone through to and fro rotation. After
cavity penetration, stillette is withdrawn and a tightly fitting syringe is
attached. Strong and brief suction done and about 0.2 ml of bone marrow
tissue with peripheral blood is collected.
Film preparation is started immediately by placing the aspirated
material on glass slide and spreading of particles done. Around 3-4 slides
are prepared using the above technique. Air dried films are then fixed
with respective stains.
1. Usual Romanowsky stain applied.
a. It gives details of the developing cells like normoblastic or
megaloblastic
b. Proportion of different cells lines like myeloid: erythroid ratio
c. Presence of cells foreign to the marrow like secondary
carcinoma, abnormal macrophages(storage disorders)
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d. Finally the cellularity of the marrow is also determined.
e. To detect leukemic cells.
2. Iron stain: To assess the amount of iron in the reticulo endothelial
stores like macrophages and as fine granules (sideroblastic granules) in
developing erythroblasts.
BONE MARROW TREPHINE BIOPSY
This is superior to bone marrow aspiration.   Done to detect types
of neoplastic cells, to detect Foci of lymphoma and used for staging of
lymphoma. The main disadvantage is that the foci of neoplasia and
hypoplasia are not evenly distributed and single biopsy may not be useful
INDICATIONS OF BONE MARROW BIOPSY
1. Myelodysplastic syndrome
2. Pancytopenias
3. Monoclonal gammopathy
4.  Undiagnosed and untreated anemia
5. Immature white and nucleated red cells
6. Indeterminate iron stores
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MYELO DYSPLASTIC SYNDROME (MDS)
Primary disorders of hemotopoiesis are common in people >65
years especially MDS with  median age of 7th decade of life. Many cases
of unexplained anemia in elderly can be because of MDS as it presents as
normocytic or macrocytic anemia, especially when only the erythroid
lineage is involved. MDS constitute a heterogeneous group of malignant
bone marrow disorder characterized by ineffective haematopoeisis  and
increased risk of leukemic evolution. It is still a morphological and
clinical diagnosis and careful assessment is required for adequate risk
evaluation. Incidence of MDS is 4.5 per 100,000 yearly.
Risk factors are smoking, exposure to organic solvents, radiation,
male patient having a first degree relative affected by hematopoietic
malignancy, patients presenting with unexplained anaemia, infection,
bleeding. Bone marrow is usually hyper or normo cellular and a minority
hypocellular.
Pathogenesis of MDS
MDS is considered as a clonal disorder of early hematopoietic
progenitor or stem cell. Increased apoptosis in the hematopoietic
progenitor resulting in peripheral cytopenia is the hallmark of MDS. A
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minority of MDS patients are on the diagnostic border of MDS, Aplastic
anaemia and Paroxsymal Noctural Hemoglobinemia .
As on date no single genetic lesion has been shown to be sufficient
for developing the disease .Pathogenesis is epileptic alteration in
promoter hypermethylation and histone deacetylation.
FEATURES SUGGESTIVE OF A PRIMARY HEMOTOLOGIAL
DISORDER
History and physical examination:
1. Splenomegaly or unexplained lymphadenopathy
2. Constitutional symptoms
a. Unexplained fever
b. Unintentional weight loss
c. Drenching night sweats
d. Bone pain
3. Treatment with Radiotherapy/Chemotherapy
Hemotological profile in MDS
1. Neutropenia or thrombocytopenia with anemia
2. Oval macrocytosis
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3. Basophilia
4. Appearance of atypical cells on peripheral blood smears
5. Early myeloid cells
6. Hypogranular or dysplastic neutrophils
7. Dacrocytes
8. Hypogranular platelets.
WHO Classification designates five categories in the spectrum of
MDS
1) Refractory anemia
2) Refractory anemia with ringed sideroblasts
3) Refractory anemia with multilineage dysplasia
4) Refractory Anemia with Excess Blast (RAEB)
5) Isolated 5q abnormality
Note: Now RAEB has been eliminated and included in the diagnosis of
AML.
ETIOLOGY of MDS
1. Exposure to benzene
2. Chemotherapeutic agents
3. Topoisomerase inhibitors
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4. Radiation
5. Genetic diseases like Fanconi’s anemia
PATHOGENESIS of MDS
These disorders arise from clonal expansion of a multipotent
hemotopoietic stem cell. Tumor suppressor genes may also play a role in
the pathogenesis of MDS. Mutated RAS is more prevalent among such
cases. The main pathophysiological process in MDS is ineffective
hemopoiesis. It implies a decreased proportion of cells in the DNA
synthesis phase and marked increase in proportion of late precursor cells
undergoing apoptosis. Immune dysregulation involving increased
apoptosis of marrow B lymphocytes is also noticed.
Nutritional Anemia
Loss of availability of balanced food due to either functional or
financial reasons plays a pivotal role in the poor nutritional status of the
elderly. Adding on the ageing changes, loss of appetite, decreased
functioning of special senses like taste and smell leads to poor food intake
and malnourishment.
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Hence assessing the nutritional status of the elderly identifying the
at risk individuals and improving their nutritional status will prevent
nutritional related disorders like anemia, tuberculosis etc.(47)
Ageing of the lympho-hemotopoietic system produces a blunted
response to any hemotopoietic stress and is associated with increased with
incidence of neoplasia, auto immune diseases and infections in elderly.
Adding these factors to the chronological age of the older person-
the functional age of the person is even higher, which accounts to greater
degree of personal and medical care.
`Iron Deficiency:
It is the commonest cause of Nutrient deficient Anemia. It is caused
by decreased oral iron intake, reduced absorption of iron, chronic blood
loss. Initially Anemia may be Normochromic and Normocytic. As the
disease advances, production of Microcytic Hypochromic cells are
characteristic.  The hematological profile of this disorder are
1. Low serum ferritin concentration
2. Low serum iron concentration
3. Increased total iron binding capacity
4. Low transferrin saturation ratio
5. Increased levels of soluble transferrin receptor.
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NORMAL NEGATIVE
IRON
BALANCE
IRON DEFICIENT
ERYTHROPOISIS
IRON
DEFICIENCY
ANEMIA
SERUM
FERRITIN(ng/dl)
50-200 <20 <15 <15
SERUM
IRON(µg/dl)
50-150 NL <50 <30
TIBC 300-360 >360 >380 >400
SATURATION
%
30-50 30-50 <20 <10
Vitamin B12 and Folate deficiency:
Folate and Vitamin B12 deficiency impairs the erythrocyte
maturation and proliferation.
Absorption of cobalamin:
Only source of cobalamin for human is food of animal origin. Daily
recommendation of cobalamin is around is 1-3 micro grams. Coblamin is
absorbed both actively and passively. Passive absorption is by buccal ,
duodenal and ileal mucosa which is  < 1%. Active absorption occurs
through ileum where the cobalamin intrinsic factor complex enters the
ileal cell.
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Absorption of folic acid:
Folate is absorbed in the upper intestine. Absorption occurs in the
form of poly glutamates which are later converted into mono glutamates.
It enters the intestine cell after converting into 5, 10 methylene
TetraHydrafolate.
Characteristic features of Vitamin B12 deficiency are macrocytosis,
presence of hyper segmented granulocytes, giant platelets,
thrombocytopenia and leucopoenia. Conditions in which B12 absorption
is decreased are hypochlorhydria, surgical procedures involving the
stomach, atrophic gastritis, intrinsic factor deficiency, small bowel
bacterial overgrowth.
Macrocytosis: Red cells are larger than a small lymphocyte and well
hemoglobinized. Often macrocytes are oval-shaped
(macroovalocytes).
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Anemia of Chronic Diseases (ACD)
The NHANES III report states that one out of every ten adults >65
years as anemic. Most common inflammatory processes causing ACD are
autoimmune disorders, infections, etc. In ACD, typically normocytic
picture is seen.
Pathology is inability to mobilize adequate iron stores from reticulo
endothelial system to blood. There is no deficiency of iron as such. In
ACD, there is low serum iron level but a low to normal iron binding
capacity. In iron deficiency iron anemia, there is a high iron binding
capacity.
Ratio of soluble transferrin receptor to log of ferritin level plays a
important role to distinguish ACD from iron deficiency. A ratio of <1
favours ACD over iron deficiency anemia. The diagnosis can also be
obtained measuring all important measure which is the serum ferritin
levels. Ferritin gives you a good measure of iron store. Since ferritin is a
important acute phase reactant, its level increases with inflammation both
in acute and chronic diseases. Thus, in iron deficiency ferritin level is
typically low whereas in ACD, ferritin levels is often high.
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POTENTIAL ROLE OF HEPCIDIN IN ACD
It is hypothesized that hepcidin plays an important role in the
anemia of inflammation. Inflammation causes activation of monocytes
and T cells to produce pro inflammatory cytokines especially interleukin
6 which in turn induces the secretion of hepcidin by hepatocytes.
Hepcidin binds to the membrane protein ferro protein and prevents the
transfer iron from the cells.
TREATMENT
         Treatment of the chronic disease responsible for the anemia is
important. But this is not possible in all cases. Transfusion is considered
where the hemoglobin level is < 8 mg/dl. Iron supplement  should not be
used in cases of ACD as there is always good iron stores in these patients.
Iron therapy is harmful in presence of chronic inflammation.
Erythropoietic drugs are found to be useful in ACD mainly in
vascular and endothelial dysfunction. Use of erythropoietin increase best
response especially with patients suffering from connective tissue
disorders and chronic diseases.
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Problems with erythropoietic drugs
a. Higher deaths with cardio vascular events
b. Progression or recurrence of certain types of cancers
c. Increased risk of venous thromboembolism
ANEMIA OF CHRONIC KIDNEY DISEASE
Erythropoietin is produced by the peritubular capillary lining cells
in the kidneys. It is triggered by decreased oxygen availability in the
kidneys. Decreased oxygen delivery can be a result of decreased renal
blood flow, heart failure, anemia and renal arteriosclerosis. Age related
decline in renal function may lead to blunted erythropoietin response and
anemia.
SPUR CELLS: Spur cells are recognized as distorted red cells
containing several irregularly distributed thornlike projections. Cells
with this morphologic abnormality are also called acanthocytes
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Treatment should maintain Hb level between 10 -12 gms/dl.
Treatment with erythropoietin offers benefit in terms of quality of life in
physical function. Time taken for the response depends on the degree of
the disease.
MINI NUTRITIONAL ASSESSMENT
The incidence of Protein Energy Malnutrition  is  very low in
community dwelling elderly which is about (5-10%). The frail elderly
population is at increased risk of  PEM and reaches values around 20 – 60
% in hospitalized/institutionalized elderly. This proportion goes unnoticed
due to the lack of significant methods to detect malnutrition in elderly
persons.(52) Malnutrition in elderly will cause greater susceptibility to
infection, longer stay in the hospital and mortality.
MNA is composed of simple measurements and questions that can
be completed in 10 min. It provides a rapid assessment of nutritional
status of the elderly people to facilitate nutrition intervention. Mini
nutritional assessment score has been validated in the elderly population
with three successive studies.(51)
1. Anthropometric measurements- height, weight, and weight loss.
2. Dietary questionnaire (eight questions related to number of meals,
food and fluid intake and autonomy of feeding)
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3. Global assessment (six questions related to the lifestyle,
medication and mobility)
4. Subjective assessment (self perception of health and nutrition)
MNA SCORE OF MAXIMUM 30 POINTS
>24  - well nourished / normal
17 – 23.5 – at risk of malnutrition / borderline
<17 – malnourished
Major advantage of MNA is that it does not require measurements
that  are  difficult  to  assess  such  as  blood  values,  but  since  it  is  a
questionnaire inter-individual variation are more. MNA score correlates
well with various aspects of health. Many studies reveal increased
mortality in elderly malnourished individuals when compared to well-
nourished individuals. MNA is a predictor of outcome and cost of care in
hospital settings, while in home care patients it is related to meal patterns
and chronic medical conditions. Overall sensitivity of MNA was 96 %
and specificity was 98 %.
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REVIEW OF LITERATURE
1. AMIT BHASIN and MEDHA Y RAO (Department of Medicine,
M S Ramaih Medical College)
Characteristics of anemia in elderly. This study was warranted to
identify the underlying cause and clinical profile of elderly patients
with anemia.
2. IZAKS GJ. et al.  (Department of general medicine, Leiden
university medical center, the Netherlands)
The objective of this study is to correlate the association between
hemoglobin concentration and cause specific mortality rate in the
elderly persons. The study was done for a period of ten years from
1986 to 1996. The study concluded that the mortality risk in
patients of age above 85 was more, when WHO criterion for
anemia is considered.
3. ZAKAI NA et al. (Department of medicine, university of Vermont,
Burlington USA)
 In this study community dwelling men and women more than 65
years were enrolled. This study also showed that anemia defined by
WHO is associated with increased mortality in patients more than
65 years.
43
4. WOODMAN R et al. (Bridgewater , NJ, USA)
NHANES III  study showed that anemia was present 11 % of men,
10.2 % of women. The ratio rises 20% more in people with age
more than 85.
5. NEUKIRCHEN J et al. Incidence and prevalence of
myelodysplastic syndrome. This study found out that the incidence
and prevalence of MDS was higher in men than in women and
increases sharply with increase in age.
6. PATEL KV et al. (National institute of ageing, Bethesda, USA)
This study concluded that anemia was associated with increased
risk death in white males. Conversely older blacks were not at risk
for adverse effects.
7. PENNIX BW et al.
This study shows anemia was associated with decline in ability of
performance assessed by short physical performance battery.
8. CHAVES et al.
This study showed a synergistic interaction between anemia and
cardio vascular disease. Study also showed the relation of anemia
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with impaired cognition by using mini mental status examination
(MMSE score).
Patient with anemia had mild impaired cognition under MMSE
score less than 24.
9. BALDUCCI et al.
This study reviewed the causes and consequences of anemia and
also highlighted the chances of stimulation of cancer growth with
erythropoietin stimulating agents.
10.Ferruci et al.
This study showed the relation between erythropoietin and
declining renal function.
11.JACK M GUARALNIK (National institute of ageing, Philadelphia)
This result shows that men are having high prevalence of anemia
than women after the age of 75, and reaches highest prevalence of
26% at 85 years of age.
12.CHOI CW et al.
 Cross sectional study of urban Korean population. This study
correlated female sex, old age, lower albumin level, higher
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creatinine level as independent risk factors for the prevalence of
anemia.
13.CAPURRO (University of Chile)
 This study correlated role of inflammation in micro nutrient
deficiency and prevalence of anemia. They concluded that anemia
was less prevalent in free living aged patient than institutionalized
elderly people.
14.ASTOR et al. (Johns Hopkins school of public health)
This study correlated the association of GFR with prevalence of
anemia. They concluded that estimated GFR below 60 ml/ min /
1.73 mts(2) was associated with higher prevalence of anemia.
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MATERIALS AND METHODOLOGY
SETTING:
Patients attending  Outpatient clinics of Department of Geriatrics
and those who are admitted in  Geriatric Medicine ward in Madras
Medical College and Rajiv Gandhi Government General Hospital,
Chennai.
ETHICAL COMMITTEE APPROVAL:
Ethical committee clearance obtained from the Institutional Ethical
committee of Madras medical college as per the meeting held on  June
2012.
STUDY DESIGN:
Cross Sectional , Clinical, Observational study
STUDY PERIOD:
June  2012 to December  2012
CONSENT:
Consent was obtained from all patients, who participated in the
study.
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FINANCIAL SUPPORT:
NIL
STUDY POPULATION:
93 patients attending both outpatient clinic and inpatients in
Department of Geriatric Medicine, Madras Medical College, Govt.
General Hospital.
INCLUSION CRITERIA:
? Age above 65yrs.
? Patients with Hb levels of <12g/dl in women and <13g/dl in men.
EXCLUSION CRITERIA:
? All Critically ill subjects.
DETAILS OF STUDY:
Total 93  subjects fulfilling the WHO criteria for anemia definition
(men Hb<13g/dl and women Hb<12g/dl) were enrolled in the study. Both
sexes were included in study group.
All 93 subjects were subjected to Mini Nutritional Assessment
questionnaire and MNA scoring was also done. All subjects
Anthropometric assessment was done and BMI, Mid-arm circumference
48
and calf circumference measurements taken. Subjects were questioned
accordingly for the answers and a total score out of 30 was obtained by
adding points for each question.
Detailed history taking and clinical examination was performed in
patients diagnosed with anaemia.
Using a dry syringe venous blood of 10ml drawn under aseptic
precautions from patients with their consent, and the following relevant
investigations done.
Hemoglobin concentration assessed in capillary blood was slightly
lower than that assessed by venous blood. This is because the capillary
blood vessel is small, the red cell volume of the capillary blood is 1-3 %
lower than the venous blood.  Considering this fact we have chosen
venous blood collection in our study.
Subjects underwent the following investigations like total and
differential counts , erythrocyte sedimentation rate , platelet count , and
red cell indices like mean corpuscular volume , Mean corpuscular
haemoglobin, mean corpuscular haemoglobin concentration , packed cell
volume, reticulocyte count  and other biochemical investigations like
renal function test and liver function test also done. Urine samples also
were taken for analysis with patients consent.
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All subjects underwent Peripheral Smear study which was the
important parameter in the classification of anemia.  Based on the patient
Peripheral Smear picture patients were classified as microcytic (MCV<
80 ), Macrocytic (MCV 80-100)  and Normocytic (MCV > 100).
Sr. Ferritin assay was done in all patients as a measure of iron
stores. Bone marrow aspiration was done in patients with blood smear
showing immature white cells, nucleated red cells ,in patients with severe
anemia , intermediate iron stores , unexplained anemia and in suspicion of
other haematological malingnancy like Myelodysplastic Syndrome.
Other additional tests include serum iron, transferrin saturation are
done for iron deficiency anemia.
For evaluation of hemolysis serum lactate dehydrogenase, indirect
bilirubin concentration is measured.
In patients with abnormal renal profile estimated Glomular
Filtration Rate (eGFR) was calculated to assess the appropriate renal
function.
To evaluate occult GI bleeding, fecal occult blood was done in all
patients. Upper GI endoscopy is done in patients with iron deficiency
anemia, in patients with stool occult blood positivity and in subjects in
whom underlying cause was not evaluated. Lower GI tract evaluation by
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LGI scopy is done in patients with stool occult blood positivity but in
whom UGI scopy was normal, to rule out malignancy and other benign
GI disorders.
Vitamin B12 and Folate assays carried out in patients with
Macrocytic anemia and  in patients with a dimorphic picture in smear and
in patients with Normocytic or Microcytic blood picture in whom no
other causative factor was detected .
Additional investigations as indicated like X- ray chest, USG
Abdomen & Pelvis, stool for parasites and serum electrophoresis & Direct
Coombs test was done for reasoning out the underlying cause.
51
RESULTS AND ANALYSIS
An observational study was carried out in a cohort of patients aged
65 years and above including either sex presenting to our hospital
fulfilling the WHO criteria for anaemia. Patient selection was very
random and non consecutive.  The study was conducted for a period of
six months.
In our study the percentage of male patients above 65 years with
anaemia was 59 % and the prevalance percentage of  females above 65
years was around 41 %. This shows that the propotion of males above 65
yrs with anemia is higher than females above 65 yrs with anemia.
41%
59%
Male - Female ratio
Female
Male
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This might be due to the lowered limit of WHO criteria based on
Hb levels for females. Also the prevalence of anemia in males increases
as age progresses with highest prevalence in males who are 85 years and
older. According to the NHANES III study the prevalence of anemia in
men was 11 % and for women was 10.2 %. Our study correlates well with
NHANES III results.
Age distribution of patients
In our study age group ranges from 65 to 81 years. The mean age
group was 73 years. According to Amit Bhasin and Medha  Y Rao  study
the mean age group was 70.51 years.
The maximum number of  patients were in age group of 65 – 69
which is the same as that of Amits study. The number of patients in the
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age group 80 and above was very less about 5 %. This might be because
of the lower life expectancy rate in this age group in developing countries
like in India. Also as age progresses the morbidity and mortality rate
associated with anemia increases exponentially.
In developed countries the prevalence of anemia is steadily
increased with ageing and found to be highest in the age group 85 +.
These significant differences were also preserved with reference to race
and ethnicity.
Age sex distribution
In our study males with anemia were more prevalent in the age
group of 65 to 79 years. Prevalence  of anemia shooted up dramatically in
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females above 80 years. This correlates with previous studies which
shows that prevalence of anemia in females increases above 85 yrs.
Severity of Anemia in both sexes
The third National Health and Nutrition Examination Survey
studied the prevalence of anemia in community dwelling persons. The
number of persons with severe anemia in fact was very less in this study.
In this 2.8% of women and 1.6% of men have hemoglobin less than 11
gms/dl. According to this study the prevalence of severe anemia was
more for women than men.  In our study the prevalence of severe anemia
was more in men than women. This might be the overall more number of
men than women in our study.
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Distribution of different types of Anemia
According to the NHANES III study anemia of chronic disease,
nutritional deficiency and unexplained anemia shared equal thirds in
prevalence. In our observational study both ACD and Nutritional anemia
shared equal proportion. Anemia of Unexplained etiology was lesser in
our study as it is an institutional study.
56
4%
38%
7%
2%
41%
2%
6%
Peripheral smear study
Macrocytic
Hypochromic
Microcytic
Hypochromic
Microcytic
Macrocytic
Hypochromic
Microcytosis
Macrocytosis
Polychromatophilic
Normocytic
Normochromic
Normocytic
Normochromic
Macrocytic
Normocytic
Normochromic
Microcytic
 Normocytic anaemia was the commonest type of anemia in our
study constituting about 41 % followed by microcytic anemia constituting
about 38%. The least prevalence was the microcytic macrocytic
polychromatophillic type of peripheral smear picture seen in MDS cases.
Many different disorders produce anemia of normocytic normochromic
type . It can  occur following loss of substantial volume of blood, or in
hemolysis. It also occurs in conditions causing bone marrow failure.
According to our study, anemia of chronic disease was the most common
and the commonest picture of anemia of chronic disease was normocytic
normochromic anemia.
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Distribution of diseases in ACD patients
In our study chronic infection was responsible for majority of
patients suffering from anemia of chronic disease . The chronic  diseases
included five cases of pneumonia , four cases of pulmonary tuberculosis
and each one case of lung abcess, abdominal tuberculosis and emphyema
. Other common causes was due to rheumatoid arthiritis , anemia due to
renal diseases and malignancy.
The proposed mechanism for anemia of chronic illness is due to
cytokines like IL- 1 and IL-6 and TNF – alpha which causes destruction
of RBC precursors and decreases in number of erythropoietin receptors
on progenitor cells.
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In our study most of the patients with anemia of chronic diseases
had Normocytic  Normochromic  picture in peripheral smear study.  The
next common picture was Microcytic Hypochromic. This is because the
main pathology of anemia of chronic disease is the effect  of cytokine on
erythropoiesis .  Microcytosis is seen as chronic disease affects the iron
metabolism and decreases its availability for erythroid precursors.
3%
18%
3%
67%
6% 3%
Peripheral smear study in ACD
Macrocytic Hypochromic
Microcytic Hypochromic
Microcytic Macrocytic
Hypochromic
Normocytic Normochromic
Normocytic Normochromic
Macrocytic
Normocytic Normochromic
Microcytic
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Distribution of Nutritional Deficiency Anemia
According to NHANES III study about 50 % of nutritional anemia
was iron deficiency anemia. In our study about 66 % of nutritional anemia
is constituted by iron deficiency anemia. This shows the burden of iron
deficiency anemia in country like India. The incidence of Vitamin B12
and Folate deficiency is around 3%. Isolated Vitamin B12 deficiency is
only 2% but when combined with Iron deficiency anemia is around 7%.
This dimorphic nature is due to nutritional causes.
2
3
1
12
0
2
4
6
8
10
12
14
B12 Deficiency Combined Folate Deficiency Iron Deficiency
No of Patients
Nutritional Anemia
Distribution of Nutritional deficiency Anemia
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Distribution in Iron deficiency Anemia
In our study the most important cause for iron deficiency anemia
was nutritional causes. This is also evident from the higher incidence of
subjects at risk of malnutrition in our study population. Occult blood loss
was also a significant cause for iron deficiency anemia. This higher
incidence highlights the importance of the need for gastrointestinal
evaluation in patients presenting with iron deficiency anemia.
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In our study patients were subjected to upper GI endoscopy to rule
out blood loss in cases presenting with signs of iron deficiency anemia.
Most of patients with iron deficiency anemia had normal endoscopic
study. Among the abnormal GI studies incidence of gastric ulcers was
more. Lesser pathologies causing iron deficiency are hookworm infection,
bulbar and duodenal ulcers.
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Correlation of Sr. Creatinine level and degree of anaemia
According to older studies anemia in older adults tends to be mild
with Hb more than 10 g /dl. In NHANES III study less than 10% of the
anemic patients had hemoglobin less than 10 g/dl. In Leiden study of
patients of 85 years, 15% of the anemic patients had severe anemia. In
institutionalized elderly people this prevalence was about 20%. In our
study 58% of men and 25% of female were severely anemic.
In CKD because of the negative acute phase reaction serum iron
levels and percentage of iron saturation are very low. Further on
analyzing the graph above the serum creatinine level does not correlate
with the degree of anemia.
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Anemia caused by chronic kidney disease  in our study showed  50
% of patients were  normocytic and normochromic  .  About 25 % of
patients   in our study with anemia of chronic disease had a microcytic
picture also. This indicates an associated iron deficiency also due to
ineffective erythropoiesis due to Erythropoietin deficiency.
Normocytic picture is usually seen because there is a defect in red
blood cell production explained by the inability of the failing kidneys to
secrete Erythropoietin. There is also excessive destruction of RBC s in
advanced renal failures, which explains the the presence of microcytic
hypochromic anaemia. Our study correlated well with the study done by
Bhalta, Aryal G et al which showed 90 % of the cases to be Normocytic,
Normochromic anaemia.
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In our study Serum Ferritin level correlated with the type of
anaemia . About 90 % of the cases of iron deficiency anaemia had serum
level less than 20 ng/dl. About 50 % of the patients suffering  from
anemia of chronic disease had  normal serum ferritin levels and 50 %
showed increased ferritin stores. In renal disease also 50 % of  patients
had normal ferritin level and 50 % had increased ferritin levels. In anemia
of unexplained etiology the ferritin status was normal in most of the
cases. Only if the serum ferritin store is not initially low further
investigations like total iron, total iron binding capacity and transferrin
saturation levels are needed.
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Correlation of serum Ferritin  in Microcytic Anemia .
Around 22 patients had Serum Ferritin levels less than 20 ng/ dl
which points to deficient iron stores. Six patients had Serum Ferritin
levels more than 100 ng/dl and 7 patients had varying iron deficiency
with ferritin levels between 20 – 100 ng/dl.
Serum ferritin measurement is the first recommended test in
evaluating microcytosis. Low ferritin level suggest iron deficiency
anemia. If the serum ferritin level is not initially low then total iron
binding capacity, transferrin saturation, serum iron level and hemoglobin
electrophoresis are done. In our study about 13 % of iron deficiency
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anemia had normal to high serum ferritin levels and  needed further
investigations.
Distribution of Nutritional status
Using the mini nutritional assessment it is always possible to find
out people who are at risk for malnutrition. Number of patients who
entered our hospital premises with obvious malnutrition was only 27
people out of 93. MNA helps us to easily pick out cases with increased
risk of malnutrition, which in our case were 56 out of 93 patients. Even in
healthy individuals, 20% of the elderly are borderline and should be
assessed for risk of malnutrition, even if albumin levels and BMI are well
within normal range.
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These results show that MNA is able to assess nutritional status in
the elderly even before severe changes in weight or albumin levels occur.
These results show a statistically significant association between
malnutrition and presence of anemia and association of low BMI and high
prevalence of Anemia. PEM appears to be a strong independent risk
factor for 1 year post discharge mortality according to Toulouse-1991.
In all types of anemia the prevalence of subjects at risk for
malnutrition were more compared to subject with obvious signs of
malnutrition. This highlights the importance of mini-nutritional
assessment in detecting elderly people moving towards malnourishment
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and the effective ways to tackle the impact of malnutrition on complex
physiology of elderly.
In iron deficiency anemia the number of patients well nourished
and healthy were more . Only one patient was well nourished in our
group.
In ACD , the number of patient who were at risk out numbered the
number of patients who are malnourished at the time of admission to the
hospital. Even in ACD the number of patients who were well nourished
were very less. This could be accounted to the negative protein balance
that is very common in chronic diseases .
In Unexplained anemia compared to other groups had significantly
large number of  well nourished elderly. This highlights the minimal role
of nutritional status in unexplained anemia.
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DISCUSSION
COMPARATIVE STUDY OF ETIOLOGIES OF ANEMIA IN
ELDERLY
ETIOLOGIES ANDREW
et al (in %)
JOOSTEN
et al (in %)
NHANES
III (in %)
OUR
STUDY
(in %)
Iron Deficiency 15-23 5-30 20 38
Vitamin B 12 0-15 5-10 14 7
Chronic Kidney
Disease
8 - 8 14
Chronic
Inflammation
15-35 30-45 20 35
Myelo Dysplastic
Syndrome
0-5 5 - 3
Unknown Etiology 17-45 15-25 34 12
In western studies the incidence of iron deficiency was less
compared to our study.  In our study the incidence is high because of the
high prevalence of iron deficiency particularly nutritional deficiency in
developing countries.  The incidence of Myelodysplastic syndrome was
similar to western statistics especially it correlated .  The incidence of
anemia of unknown etiology was higher in western countries due to the
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overlap of many hemopoietic disorders under unknown etiology. The
incidence of anemia of renal disease was higher in our study due to poor
control of comorbidities like diabetes and hypertension leading to chronic
kidney disease.
DETECTION OF MALNUTRITION IN ELDERLY ON
ADMISSION TO HOSPITAL
NUTRITIONAL
STATUS
MOWE & BAHMER
et al
PERSSON MD
 et al
OUR STUDY
DETECTED
MALNOURISHED
(<90% OF
NORMAL WEIGHT
FOR HEIGHT)
55%             56% 60%
RECOGNISED AS
MALNOURISHED
ON ADMISSION
36% 26% 29%
NUTRITIONALLY
STABLE
8% 18% 11%
Our study attempted to correlate the association between the
nutritional status and presence of anemia. Nutritional status was assessed
by Mini Nutritional Assessment scale which is a very valid tool to assess
the nutritional status of ageing population. It has the specificity of 98%
and a sensitivity of 96% and a positive predictive value of 97%. These
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results showed a statistically significant association between malnutrition
and presence of anemia. Further association between low BMI and high
prevalence of anemia was also found. This study also shows the
usefulness of Mini Nutritional Anemia in assessing the patients at risk for
malnutrition. Only 29% of patients were malnourished at the time of
admission. About 60% of the patients were detected at risk of
malnourishment which was made possible by a valuable tool - MNA
DISTRIBUTION OF MYELO DYSPLASTIC ANEMIA
ETIOLOGY % OF ANEMIC CASES
MYELODYSPLASIA 3
HEMATOLOGICAL
MALIGNANCY
2
In our study hematological malignancies contributed to 5 % of
anemia  of  which  the  prevalence  of  MDS  was  3%  and  that  of
hematological malignancy 2%. The prevalence of MDS was much higher
in our study when compared to others.
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NUTRITIONAL DEFICIENCY ANAEMIA
NUTRITIONAL
ANEMIA
AMIT BASIN &
MEDHA RAO
et al
JACK & CO
WORKERS
et al
OUR
STUDY
Iron Deficiency 30 % 16.6 % 26%
VIT B12 Deficiency 3% 5.9 % 2%
Folate Deficiency 2 % 6.4 % 1%
Incidence of iron deficiency anemia is maximum in our study
which could be attributed to these factors common in our population
1. Insufficient dietary intake
2. Mal-absorption in elderly
3. Chronic bleeding
4. Worm infestations
5. Gastric disorders.
Hence our study corroborates the finding of these studies, Iron
deficiency being the most common Nutrition deficient anemia.
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ANEMIA OF UNEXPLAINED ETIOLOGY
NHANES	III	 30%	Beghe	et	al	 14.50 %Jack	&	Co	Worker	et	al	 33.6 %Amit	Bhasin	 2%Our	Study	 11.8%
In our study anemia of unexplained etiology is around 11.8 %
which is relatively low compared to the western studies.  In this disorder
anemia is relatively mild is often overlooked .We believe that this
disorder is not as mysterious as it is complex. Factors contributing this
disorder are
1. Age related decline in renal endocrine function
2. Age related relation in androgen levels
3. Decreased stem cell proliferation
4. Early MDS presenting as anemia without classical features
5. Proinflammatory cytokine dysregulation
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Contribution of these factors account for the observed clinical
heterogeneity. Our study correlates well with the studies of Beghe et al
and Jack & Co Worker et al.
ANEMIA OF CHRONIC DISEASE (ACD)
STUDY RESULTS
Amit Bhasin et al 48%
NHANES III 30%
Our study 35%
From these studies it is evident that ACD forms the most important
cause of anemia in elderly. In Amit Bhasin et al study prevalence of ACD
is more followed by Iron deficiency anemia followed by a small
proportion of blood loss anemia. In Elejalde Guerra et al study prevalence
of Iron deficiency anemia was more than other types of anemia. Our study
correlated well with Amit Bhasin et al study. As both were done from the
same population.
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ANEMIA OF CHRONIC RENAL DISEASE
STUDY RESULTS
Jack and Co Worker et al 13.2%
Amit Bhasin et al 22%
Our Study 14%
The prevalence of Anemia of chronic renal disease in our study was
next only to ACD and Iron Deficiency Anemia.
STUDY ON IRON STORES
STUDY Sreum Ferritin less than 20 ng/dl
Amit Bhasin et al 11%
Milman & Schultz – Larsen 5.9%
Our Study 22%
Serum Ferritin reflects the total body iron stores. From these
results, we can infer that the iron stores are very less in Indian population.
And hence they are prone for anemic symptoms as age progresses.
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NORMOCYTIC ANEMIA
STUDY Percentage of Normocytic
Anemia in peripheral smear
Amit Bhasin et al 62%
Elis et al 60%
Amiasal 62%
Our study 41%
The table above shows that the Normocytic blood picture is the
commonest diagnosis in peripheral smear for patients above 65 years of
age. Thus, Normocytic blood picture should not be disregarded as a
normal peripheral smear picture.
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Analytical report
? Prevalence of anemia is more in males in the age group above 65
years.
? Mean age group was 73 years and the maximum number of patients
were in the age group of 65-69 years.
? As age increases above 85 yrs prevalence of anemia shooted up
dramatically in females.
? Severe anemia is more common in males than females.
? Anemia of chronic disease is the most common anemia followed by
iron deficiency anemia.
? Normocytic normochromic anemia and microcytic and
hypochromic anemia are the most common peripheral smear
pictures in our study.
? Normocytic normochromic study is the commonest peripheral
study in ACD.
? MNA  was  able  to  identify  56  patients  who  were  at  risk  for
malnutrition.
? Nutritional anemia is the commonest cause for iron deficiency
anemia.
? Inflammatory disease were the commonest cause for anemia in
chronic disease.
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? Normocytic normochromic picture is the commonest peripheral
smear picture in both anemia of renal disease and ACD.
? Low serum ferritin store is exclusively seen in iron deficiency
anemia.
? Combined deficiency is more common than  isolated Vit B 12  or
Folate deficiency.
? Anemia of unexplained etiology was very less in our study when
compared to western studies .
? Incidence of MDS is 3 %  which is very high compared to other
studies
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CONCLUSION
Our study highlights the fact that most elderly people who are
anemic have an underlying cause for anemia. The physician should be
aware of the co-existence of anemia with other ailments. It is therefore
pertinent to find out the reason for the types of anemia, the possible
etiologies and the severity of anemia. Normocytic blood picture in anemic
elderly should not be disregarded as it is the commonest blood picture.
Attention should be paid towards the nutrition of the geriatric
population as the number of patients who are at risk for malnutrition was
very high. Delay in evaluating elder patients for anemia can lead to
delayed diagnosis of potentially treatable disease. Non specific
complaints like fatigueness and weakness should not be ignored, as these
symptoms can be an indication for anemia. Protocol should always be
followed to arrive at the etiology of diagnosis before specific treatment is
given for the disease.
Primary care providers must be proficient in the initial work-up of
the anemic elder. Often, there are multiple medical comorbidities
requiring specialist referral. A good working relationship with
gastroenterologists and hematologists is important, and nephrology
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referral may be indicated for patients with chronic kidney disease. It is up
to the primary care clinician to accumulate all pertinent information from
specialists and diagnostics and to establish a plan of care that will benefit
the patient.
BIBILOGRAPHY
1. Price EA, Schrier SL. Anemia in the elderly: introduction.
SeminHematol 2008; 45:207.
2. AMIT BHASIN and MEDHA Y RAO (Department of Medicine,
M S Ramaih Medical College) Characteristics of anemia in elderly.
3.  Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of
anemia in persons 65 years and older in the United States: evidence
for a high rate of unexplained anemia. Blood 2004; 104:2263.
4. Price EA, Mehra R, Holmes TH, Schrier SL. Anemia in older
persons: etiology and evaluation. Blood Cells Mol Dis 2011;
46:159.
5. NEUKIRCHEN J et al. Incidence and prevalence of
myelodysplastic syndrome.Pang WW, Schrier SL. Anemia in the
elderly. Curr Opin Hematol 2012; 19:133.
6.  Merchant AA, Roy CN. Not so benign haematology: anaemia of
the elderly. Br J Haematol 2012; 156:173.
7.  Nutritional anaemias. Report of a WHO scientific group. World
Health Organ Tech Rep Ser 1968; 405:5.
8.  KILPATRICK GS, HARDISTY RM. The prevalence of anaemia
in the community. A survey of a random sample of the population.
Br Med J 1961; 1:778.
9.  Beutler E, Waalen J. The definition of anemia: what is the lower
limit of normal of the blood hemoglobin concentration? Blood
2006; 107:1747.
10.  Beutler E, West C. Hematologic differences between African-
Americans and whites: the roles of iron deficiency and alpha-
thalassemia on hemoglobin levels and mean corpuscular volume.
Blood 2005; 106:740.
11. Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Haematological
abnormalities and reference intervals in the elderly. A cross-
sectional comparative study of three urban Swedish population
samples aged 70, 75 and 81 years. Acta Med Scand 1988; 224:595.
12.  Nilsson-Ehle H, Jagenburg R, Landahl S, et al. Decline of blood
haemoglobin in the aged: a longitudinal study of an urban Swedish
population from age 70 to 81. Br J Haematol 1989; 71:437.
13.  Patel KV. Epidemiology of anemia in older adults.SeminHematol
2008; 45:210.
14.  Culleton  BF,  Manns  BJ,  Zhang  J,  et  al.  Impact  of  anemia  on
hospitalization and mortality in older adults. Blood 2006;
107:3841.
15. Patel KV, Harris TB, Faulhaber M, et al. Racial variation in the
relationship of anemia with mortality and mobility disability
among older adults. Blood 2007; 109:4663.
16.  Penninx BW, Guralnik JM, Onder G, et al. Anemia and decline in
physical performance among older persons. Am J Med 2003;
115:104.
17.  Izaks GJ, Westendorp RG, Knook DL.The definition of anemia in
older persons. JAMA 1999; 281:1714.
18.  Artz AS, Fergusson D, Drinka PJ, et al. Mechanisms of
unexplained anemia in the nursing home. J Am GeriatrSoc 2004;
52:423.
19. Baldwin JG Jr. Hematopoietic function in the elderly. Arch Intern
Med 1988; 148:2544.
20. Balducci L. Epidemiology of anemia in the elderly: information on
diagnostic evaluation. J Am GeriatrSoc 2003; 51:S2.
21. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an
innocent bystander? Arch Intern Med 2003; 163:1400.
22. Beghé C, Wilson A, Ershler WB. Prevalence and outcomes of
anemia in geriatrics: a systematic review of the literature. Am J
Med 2004; 116 Suppl7A:3S.
23. Salive ME, Cornoni-Huntley J, Guralnik JM, et al. Anemia and
hemoglobin levels in older persons: relationship with age, gender,
and health status. J Am GeriatrSoc 1992; 40:489.
24. Anía BJ, Suman VJ, Fairbanks VF, Melton LJ 3rd. Prevalence of
anemia in medical practice: community versus referral patients.
Mayo ClinProc 1994; 69:730.
25. Den Elzen WP, Westendorp RG, Frölich M, et al. Vitamin B12 and
folate and the risk of anemia in old age: the Leiden 85-Plus Study.
Arch Intern Med 2008; 168:2238.
26.  den Elzen WP, Willems JM, Westendorp RG, et al. Effect of
anemia and comorbidity on functional status and mortality in old
age: results from the Leiden 85-plus Study. CMAJ 2009; 181:151.
27. Older Americans update 2008: Key indicators of well-being.
Federal Interagency Forum on Aging-related Statistics, US
Government Printing Office, Washington, DC 2008.
28.  Singh PM, Anita P, Vedpal D. Prevalence of anemia in an elderly
rural population of northern India. J Am GeriatrSoc 2009; 57:355.
29.  Chaves PH, Semba RD, Leng SX, et al. Impact of anemia and
cardiovascular disease on frailty status of community-dwelling
older women: the Women's Health and Aging Studies I and II. J
Gerontol A BiolSci Med Sci 2005; 60:729.
30.  Chaves PH, Xue QL, Guralnik JM, et al. What constitutes normal
hemoglobin concentration in community-dwelling disabled older
women? J Am GeriatrSoc 2004; 52:1811.
31.  Chaves PH. Functional outcomes of anemia in older adults.
SeminHematol 2008; 45:255.
32. Artz AS. Anemia and the frail elderly.SeminHematol 2008;
45:261.
33. Mindell J, Moody A, Ali A, Hirani V. Using longitudinal data from
the Health Survey for England to resolve discrepancies in
thresholds for haemoglobin in older adults. Br J Haematol 2012.
34. Fried LP, Guralnik JM. Disability in older adults: evidence
regarding significance, etiology, and risk. J Am GeriatrSoc 1997;
45:92.
35. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the
relationship between hemoglobin concentration and prevalent
mobility difficulty in older women. Should the criteria currently
used to define anemia in older people be reevaluated? J Am
GeriatrSoc 2002; 50:1257.
36.  Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with
disability and decreased physical performance and muscle strength
in the elderly. J Am GeriatrSoc 2004; 52:719.
37. Thein M, Ershler WB, Artz AS, et al. Diminished quality of life
and physical function in community-dwelling elderly with anemia.
Medicine (Baltimore) 2009; 88:107.
38. Penninx BW, Pluijm SM, Lips P, et al. Late-life anemia is
associated with increased risk of recurrent falls. J Am GeriatrSoc
2005; 53:2106.
39. Lucca U, Tettamanti M, Mosconi P, et al. Association of mild
anemia with cognitive, functional, mood and quality of life
outcomes in the elderly: the "Health and Anemia" study. PLoS One
2008; 3:e1920.
40. Chaves PH, Carlson MC, Ferrucci L, et al. Association between
mild anemia and executive function impairment in community-
dwelling older women: The Women's Health and Aging Study II. J
Am GeriatrSoc 2006; 54:1429.
41. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on
mortality, cognition, and function in community-dwelling elderly.
Am J Med 2006; 119:327.
42. Kikuchi M, Inagaki T, Shinagawa N. Five-year survival of older
people with anemia: variation with hemoglobin concentration. J
Am GeriatrSoc 2001; 49:1226.
43. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the
risk of cardiovascular disease--the Framingham study: a 34-year
follow-up. Am Heart J 1994; 127:674.
44. Patel KV, Longo DL, Ershler WB, et al. Haemoglobin
concentration and the risk of death in older adults: differences by
race/ethnicity in the NHANES III follow-up. Br J Haematol 2009;
145:514.
45. Dong X, Mendes de Leon C, Artz A, et al. A population-based
study of hemoglobin, race, and mortality in elderly persons. J
Gerontol A BiolSci Med Sci 2008; 63:873.
46.  Artz A, Dong X. Defining anemia by race using epidemiologic
data. Blood 2008; 111:2941; author reply 2941.
47.  Semba RD, Ricks MO, Ferrucci L, et al. Types of anemia and
mortality among older disabled women living in the community:
the Women's Health and Aging Study I. Aging ClinExp Res 2007;
19:259.
48.  Carmel R. Nutritional anemias and the elderly. SeminHematol
2008; 45:225.
49.  Carmel R, Green R, Rosenblatt DS, Watkins D. Update on
cobalamin, folate, and homocysteine. Hematology Am
SocHematolEduc Program 2003; :62.
50.  Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of
cobalamin deficiency in elderly outpatients. J Am GeriatrSoc 1992;
40:1197.
51. Blenda MJ , Bolibar I , Pares R, Salva A . reliability of mini
nutritional assessment in institutionalized elderly people . J Nutr
Health Aging 2002 : 6 : 134-137
52. Guigoz , Y ., Lauque, S & Vellas, B. J.. 2002 . identifying the
elderly at risk of malnutrition . The MNA . Clin. Geriar. Med.
ANEMIA IN ELDERLY – PROFORMA
Name: Age: Sex:
Address: Occupation:
Duration and details of illness:
History of :
? Malaise / dizziness / giddiness
? Loss of appetite
? Poor food intake
? Dysphagia
? Dyspnoe / breathlessness
? Swelling of legs
? Passing worms in stool
? Malena
? Bone pain
? Prolonged drug intake
? Previous blood transfusions
? Previous Dialysis
? Type of food intake Veg  / Non- Veg
 Past history:
? Hypertension
? Diabetes
? CAD
? Tuberculosis
? Hypothyroidism
? CKD
DRUG HISTORY:
PERSONAL HISTORY:
    Smoking     Alcoholism
GENERAL EXAMINATION:
VITALS
CLINICAL  SIGNS
? PALLOR
? GLOSSITIS
? KOILONYCHIA
? PEDAL EDEMA
? LYMPHADENOPATHY
? SPLENOMEGALY  / HEPATOMEGALY /
HEPATOSPLENOMEGALY
? RAISED JVP
SYSTEMIC EXAMINATION:
CVS:
RS:
ABDOMEN:
CNS:
INVESTIGATIONS:
Hb: TC:  DC:  P-     L-         E-         M-    Plt:
ESR:
PACKED CELL VOLUME :
MCV :
MCH :
MCHC :
RBC  COUNT :
RDW :
RETICULOCYTE  COUNT           :
PERIPHERAL SMEAR :
SERUM FERRITIN :
SERUM LDH :
BLOOD GROUPING :
BLOOD UREA :
SERUM CREATININE :
STOOL OCCULT BLOOD :
MOTION OVA CYST :
BONE MARROW STUDY :
SPECIFIC INVESTIGATIONS FOR SELECTED PATIENTS
SERUM ELECTROPHORESIS :
URINE BJP :
VITAMIN B12 ASSAY :
UPPER G.I. ENDOSCOPY :
URINE EXAMINATION :
Sugar : Deposits:
Albumin :
ECG:
X-RAY CHEST PA VIEW :
USG ABDOMEN :
NUTRITIONAL  ASSESSMENT :
MINI NUTRITIONAL ASSESSMENT
Name: Age:  Sex:
Weight  kg. Height cm
PART I .          ANTHROPOMETRIC ASSESSMENT
1. Body Mass Index(weight in Kg)/(height in m) =
a. BMI < 19          = 0 points
b. BMI 19 to < 21 = 1 point
c. BMI 21 to < 23 = 2 points
d. BMI > 23          = 3 points
Points
_______
2. Measure of Mid –arm circumference (MAC) in cm.
        a. MAC   < 21 cm.          = 0.0 points
        b. MAC   21 < 22 cm.      = 0.5 points
        c. MAC >22 cm.              = 1.0 points
_______
3. Measure of Calf circumference (CC) in cm.
         a. CC < 31 cm                 = 0 points
         b. CC > 31 cm                 =1 point
_______
4. Have you had a weight loss during the last 3 months
a.  weight loss greater than 3 kg(6.6 lbs.)
                                                              =  0 points
b. does not know                                 = 1 point
c. weight loss between 1 and 3 kg.
                        (2.2 lbs. and 6.6 kg.)     =  2 points
d. no weight loss =  3 points
_______
 Total points for this section   I                                  =   _______
PART II.   GENERAL ASSESSMENT
1. Do you live independently? (not in Nursing home or
Assisted living)
a. No = 0 points
b. Yes = 1 point
______
2. Do you take more than 3 prescription drugs per day?
a. Yes  =  0 points
b. No   = 1 point
______
3. Have you suffered from Psychological stress or an acute
illness in the past 3 months?
a. Yes =  0 points
b. No   = 2 point
______
4. Mobility:
          a. You use a wheel chair                 = 0 points
          b. You are able to get out of a bed /chair
              but does not go out alone                = 1 point
         c. You go out independently           = 2 points
______
5. Neuropsychological Problems:
a.  has severe dementia or depression   = 0 points
b. mild dementia                                   = 1 point
c. no psychological problems               = 2 points
Mini Mental State Score ________/30
______
6. Skin condition:
       Do you have any sores or ulcers (body check)
a. Yes = 0 points
b. No = 1 point
______
Total points for this section   II                                 =   _______
PART III.   SELF ASSESSMENT
1. Do you view yourself as having nutritional problems?
a. Yes -major problems with malnutrition    = 0 points
b. Does not know or has moderate problems = 1 point
c. NO –do not have nutrition problems       =  2 points
______
2. In comparison with other people of the same age, how do you
compare your health status?
a. Not as good  = 0.0 points
b. Do not know = 0.5 points
c. As good as others  = 1.0 points
d. Better than most    = 2.0 points
______
Total points for this section   III                                  =   _______
PART   IV   DIETARY ASSESSMENT
1. How many full meals do you eat daily?
a. 1 full meal  daily   =   0 points
b. 2 full meals daily  =   1 point
c. 3 full meals daily  =   2 points ______
2. Selected consumption markers for protein intake
? At least one serving of dairy products (milk, cheese,
yogurt) per day?  Yes____ No____
? Two or more servings of legumes or eggs per week?
Yes___ No ____
? Meat, Fish, or Poultry every day?
      Yes____ No____
a. If   0 or 1 Yes responses = 0.0 points
b. If 2 Yes responses          = 0.5 points
       c.   If 3 yes responses           = 1.0 points
_______
3. Do you consume 2 or more servings of fruits or vegetables per
day?
a. No =  0 points
b. Yes = 1 point
______
4. Has your food intake declined over the past three months due
to loss of appetite, digestive problems, chewing or swallowing
problems?
a. severe loss of appetite = 0 points
b. moderate loss of appetite = 1 point
c. no loss of appetite            = 2 points
______
5. How much fluid (water, juice, tea, milk …)do you consume
daily?
(1 cup = 8 ounces)
a. less than 3 cups = 0.0 points
b. 3 to 5 cups         = 0.5 points
c. More than 5 cups = 1.0 points
______
6. Ability to feed self
a. requires assistance with meals/feeding           = 0 points
b. able to feed self, but has some difficulty        = 1 point
c. able to feed self independently (no problems) = 2 points
______
Total points for Section IV Dietary Assessment     -----------------
            Section I Anthropometric Assessment Points      -----------------
            Section II General Assessment   Points     -----------------
       Section III Self Assessment Points                 -----------------
 ASSESSMENT TOTAL POINTS (maximum  30 points))
     TOTAL  =      ___________
                           MALNUTRITION INDICATOR SCORE
                 > 24 points                   = Well nourished
                17 to 23.5 points              =  at risk for malnutrition
                < 17 points                      = malnourished
PATIENT CONSENT FORM
     Study Detail : “ANEMIA IN AGEING POPULATION - A STUDY
OF PREVALENCE & CAUSES ”
    Study Centre : Rajiv Gandhi Government General Hospital, Chennai.
    Patient’s Name :
    Patient’s Age :
    Identification
    Number
:
Patient may check (?) these boxes
a) I confirm that I have understood the purpose of procedure for the
above study. I have the opportunity to ask question and all my
questions and doubts have been answered to my complete
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?
b) I understand that my participation in the study is voluntary and that I
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legal rights being affected.
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c) I understand that sponsor of the clinical study, others working on the
sponsor’s behalf, the ethical committee and the regulatory authorities
will not need my permission to look at my health records, both in
respect of current study and any further research that may be
conducted in relation to it, even if I withdraw from the study I agree
to this access. However, I understand that my identity will not be
revealed in any information released to third parties or published,
unless as required under the law. I agree not to restrict the use of any
data or results that arise from this study.
?
d) I agree to take part in the above study and to comply with the
instructions given during the study and faithfully cooperate with the
study team and to immediately inform the study staff if I suffer from
any deterioration in my health or well being or any unexpected or
unusual symptoms.
?
e) I hereby consent to participate in this study. ?
f) I hereby give permission to undergo complete clinical examination
and hematological
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TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
31 32 33 34 35 36 37 38 39
71 75 65 72 66 66 67 73 78
F M M F M F M F F
10.6 6.5 10.6 9.9 9.8 9.2 12.4 11.2 9.9
14800 6500 4800 5300 6100 6400 7000 9400 5300
30 64 28 30 40 20/40 13 58 30
1.55 1.80 1.75 2.76 1.00 2.40 1.80 1.80 2.76
31 21 30 30 30 30 38 34 34.7
86 88 90 85 88 78 84 80 90
31.4 32 33 32.8 31.4 31.6 33 34 33
3 1.96 3.12 2.96 3.8 2.9 3.5 3.14 3
0.5 1.2 2 1.5 1 0.2 2 0.8 1.4
436 188 162 342 176 190 493 227 156
256 88 84 143 106 12 68 46 94
- - - - - - - - -
36 36 58 18 74 28 26 18 22
1.2 1.2 2.9 0.8 2.2 0.8 0.9 0.7 0.9
Normo Normo Normo Normo Normo Normo Micro Normo Normo Normo Normo Micro Hypo Normo Normo Micro Hypo Normo Normo
Increased Normal Normal Normal Normal Normal Normal Increased Normal
Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate
- - - - - Clumps+ - - -
- Normal - Normal - - Normal - Normal
Neg Neg Neg Neg Neg Pos Neg Neg Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Normal Normal Normal Normal Normal Normal Normal
- - - - - Colon Polyt - - -
- Sr Fe 164 μg/dl Sr.Fe 60μg/dl - - Sr Fe 38 μg/dl
Sr Fe 120 
μg/dl Sr Fe 94μg/dl -
16 20.5 15.5 16 25 16.5 24.5 23 24
Malnourished At Risk Malnourished Malnourished Wellnourished Malnourished Wellnourished At Risk Wellnourished
Emphyema  - CKD Thyroid Malignancy CKD Blood Loss AWMI Pneumonia  -
ACD Unexplained  Renal Disease + Iron def ACD Renal Disease Iron Deficiency Unexplained ACD Unexplained
RBC
WBC
Platelets
Abnormal 
Cells
MCV
Pt. No
Age
Sex
Hb (gm/dl)
TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
40 41 42 43 44 45 46 47 48 49 50
73 68 70 66 65 68 69 76 82 67 68
M M M M F F M M F F M
11.4 10.6 8.4 11.0 4.4 8.4 10.0 10.2 8.6 8.5 10.6
6800 7300 9200 8000 2500 6300 6000 6800 4000 5400 4800
22 36 36 45 24 54 8 30 55 46 28
4.32 2.10 1.50 1.38 1.10 1.85 1.92 1.72 1.20 1.40 1.75
34 32 26 33 18 30 39 30 35 25 30
92 94 96 94 58 84 78 74 70 68 88
34 33 32 34 28.4 32.3 34 29.4 28.4 27.9 32.4
3.24 3 3 3.14 1.44 2.1 3.24 2.9 2.1 2.24 3.2
1.2 1 1.8 1 0.9 0.5 1.2 0.5 1.2 1.2 2
247 885 202 460 339 193 183 395 277 473 162
20 98 106 198 578 96 76 12 10 16 86
- - - - - - - - - - -
28 48 45 32 29 27 26 27 36 34 28
0.9 1.8 1.1 1 1 1.1 0.9 1 1.1 1 1
Normo Normo Normo Normo Normo Normo Normo Normo Micro Hypo Normo Normo
Normo Normo 
Micro Micro Hypo Micro Hypo Micro Hypo Normo Normo
Normal Normal Normal - Decreased Normal Normal Normal Normal Normal Normal
Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate
- - -
Atypical 
Lymphocytes 
10% - - - - Poikilocytosis - -
- - Normal
Atypical cells - 
20% Hypocellular - Normal - - - -
Pos Neg Neg Neg Pos Neg Neg Neg Neg Pos Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Normal Normal Antral Gastritis Normal Normal Normal Normal Normal -
- - - - - - - - - - -
Hemorrhoids - Sr Fe 134μg/dl - Sr.Fe 40μg/dl -
Sr.Fe 
140μg/dl Sr Fe 52μg/dl Sr Fe 62μg/dl Hemorrhoids Sr Fe98μg/dl
22 22.5 20.5 23 15.5 19.5 22.5 23 19.5 16.5 23
At Risk At Risk At Risk At Risk Malnourished At Risk At Risk At Risk At Risk Malnourished At Risk
Blood Loss CKD  - Lung MalignancyGI Malignancy LORA         - Nutritional Nutritional Blood Loss CVA
Iron Deficiency Renal Disease Unexplained ACD ACD + Iron def ACD Unexplained Iron Deficiency Iron Deficiency Iron Deficiency ACD
RBC
WBC
Platelets
Abnormal 
Cells
MCV
Pt. No
Age
Sex
Hb (gm/dl)
TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
51 52 53 54 55 56 57 58 59 60 61
66 77 65 80 70 67 75 66 65 78 69
F F M F M M M M F M M
10.3 7.0 11.4 8.6 7.0 10.0 12.0 6.9 8.6 9.8 6.5
8100 4200 6800 4000 8000 4400 6100 8100 7800 6500 7400
14 65 40 55 56 26 18 58 25 45 18
1.18 1.80 2.10 1.20 2.15 1.66 2.18 1.60 1.80 2.10 1.84
32 21 39 25 21 30 36 20 28 30 19
72 88 92 88 80 74 96 78 90 89 90
33 28.4 34 32.2 33.5 32.6 33.8 33 34 32.4 33.8
3.1 2.89 3.89 3 3.1 2.9 3.2 2.24 2.14 3.1 2.64
1 0.5 1.9 1.6 0.8 0.5 0.8 0.8 0.5 0.9 0.2
205 298 364 277 659 362 90 167 193 354 110
14 58 36 96 76 18 24 43 88 44.6 72
- - - - - - B band - - - -
32 66 28 36 173 38 28 110 58 33 28
1 2.1 0.9 1.1 4 1.2 1.2 5.8 1.8 0.8 0.8
Micro Hypo Normo Normo Normo Normo Normo Normo Micro Hypo Micro Hypo
Micro Macro 
Hypo
Normo Normo 
Micro Normo Normo Normo Normo Normo Normo
Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal
Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate
Anisocytosis, 
Poikilocytosis - - - Burr Cells - - Burr Cells - - -
Hypocellular Normal Normal Normal Hypocellular - Dimorphic Hypocellular - - -
Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Normal Normal Antral Gastritis Normal Normal Normal Normal Normal Normal
- - - - - - - - - - -
Sr Fe 28μg/dl - Sr Fe144μg/dl Sr Fe 123μg/dl Sr.Fe114μg/dl Sr Fe52μg/dl
Vit B12 160 Sr 
Fe 40μg/dl Sr.Fe 60μg/dl - Sr Fe54μg/dl -
16.5 21.5 25 22.5 16.5 23 20.5 17.5 25.5 22.5 22
Malnourished At Risk Wellnourished At Risk Malnourished At Risk At Risk At Risk Wellnourished At Risk
Nutritional CKD - - CKD Nutritional Nutritional CKD CKD Lung Malignancy OA
Iron Deficiency Renal Disease Unexplained Unexplained Renal Disease Iron Deficiency CombinedRenal Disease + Iron defR nal Disease ACD + Iron def ACD
RBC
WBC
Platelets
Abnormal 
Cells
MCV
Pt. No
Age
Sex
Hb (gm/dl)
TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
62 63 64 65 66 67 68 69 70 71 72
68 68 66 68 70 65 72 70 71 69 67
F F M M M M F M M M F
3.0 9.0 6.5 9.8 7.0 8.2 9.1 7.6 8.1 8.8 9.8
3000 6800 5400 6600 11400 9400 7400 8400 9800 3400 40000
90 58 28 84 90 114 38 34 74 36 102
2.80 1.90 1.98 1.94 1.90 1.80 2.00 1.69 1.60 0.86 0.98
9 29 22 30 26 28 28 21 24 29 20
57 76 94 86 86 84 88 76 85 108 32
25.6 32.8 34.2 32.4 33 32 33.4 32 33 34 30
1.6 2.24 1.64 1.98 2.01 2.1 2.14 1.84 1.96 1.8 1.4
0.05 1.2 0.8 2 0.8 1 1 0.6 0.8 1 0.5
174 184 194 146 214 179 236 196 166 188 649
10 106 22 39 72 162 173 16 83 42 344
- - - - - - - - - - -
28 32 34 26 31 26 28 32 32 32 24
1 0.8 0.8 0.8 0.9 0.7 1 1 0.9 0.8 1.1
Micro Hypo Micro Hypo
Micro Macro 
Hypo Normo Normo Normo Normo Normo Normo Normo Normo Micro Hypo Normo Normo Macro Hypo Normo Normo
Decreased Normal Normal Normal Increased Normal Normal Normal Increased Decreased Increased
Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Decreased Decreased
- - - - - - - Poikilocytosis - Spur Cells
Blast 10% 
Smear Cells
Hypocellular, 
No Blast - Dymorphic Normal - - - Hypocellular -
Megakaryocyt
es increase 
cellularity
Hypoceellular, 
> 30 % blast
Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Post GJ Gastritis Normal Normal Normal Normal Normal Normal Varices Normal
Normal - - - - - - - - - -
- -
Vit B12 150 Sr 
Fe 38μg/dl Sr Fe 132μg/dl - - Sr Fe 104μg/dl Sr Fe 55μg/dl - -
14 16 19.5 25.5 19.5 20 22.5 24.5 23 14.5 21
Malnourished Malnourished At Risk Wellnourished At Risk At Risk At Risk Wellnourished At Risk Malnourished At Risk
Nutritional PT Sequalae Post GJ  - Pneumonia LORA PT Sequalae Nutritional Pneumonia DCLD CLL
Iron Deficiency ACD Combined Unexplained ACD ACD ACD Iron Deficiency ACD ACD HD
RBC
WBC
Platelets
Abnormal 
Cells
MCV
Pt. No
Age
Sex
Hb (gm/dl)
TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
73 74 75 76 77 78 79 80 81 82 83
68 65 70 65 72 70 70 65 69 68 69
M F M F M M M M M M M
7.1 4.1 7.4 8.8 8.0 9.0 8.8 7.1 8.5 4.6 6.0
4000 2400 7600 8400 7400 6200 5800 6200 7200 4600 4800
45 66 46 84 76 70 56 18 14 70 28/60
0.96 0.24 1.60 1.80 1.90 1.40 1.80 1.90 1.50 1.80 1.20
22 24 22 24 26 30 28 21 22 19 21
114 64 90 94 78 85 86 76 78 70 74
35 32 34 36 33.1 34 32 30 30 28 30
3.4 2.8 3.5 3 3.2 3 2.8 3.4 3.1 2.4 2.8
1.2 0.2 0.8 1 0.8 1 0.9 0.8 1 0.2 0.9
340 176 198 204 266 146 210 179 208 266 148
72 452 110 124 49 166 89 16 12 10 94
- Normal - - - Normal - - - - -
38 32 98 74 24 24 30 28 29 30 32
0.8 0.9 4.4 2.3 0.8 0.8 1 0.8 0.9 1.1 1
Macro Hypo Micro Hypo Normo Normo Normo Normo Micro Hypo Normo Normo Normo Normo Micro Hypo Micro Hypo Micro Hypo Micro Hypo
Normal Decreased Normal Normal Normal Normal Normal Normal Normal Normal Normal
Adequate Decreased Adequate Adequate Adequate Adequate Adequate Adequate Adequate Adequate Decreased
- - Burr Cells - - - - - Poikilocytosis Poikilocytosis
Target 
Cells,Gaint 
Cells
megakaryopoi
esis Hypocellular - - - - - Hypocellular Hypocellular Hypocellular
Hypercellular, 
Megakaryocyt
osis
Neg Neg Neg Neg Neg Neg Neg Neg Neg Pos Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Normal Normal Normal Normal Normal Peptic Ulcer Normal Hookworms Normal
- - - - - - - - - - -
vitb12_110 - -
Sr.Fe 
102μg/dl - - - Sr Fe 48μg/dl - Sr Fe 32μg/dl -
16.5 16 18.5 20 19.5 22.5 24.5 21.5 20 16.5 15.5
Malnourished Malnourished At Risk At Risk At Risk At Risk Wellnourished At Risk At Risk Malnourished Malnourished
B12 Deficiency GI Malignancy CKD CKD Rh - Arthritis OA Hypothyroid Blood Loss Colorectal CA Blood Loss MDS
Megaloblastic ACD Renal DiseaseRenal Disease + ACD ACD ACD ACD Iron Deficiency Iron Deficiency Iron Deficiency HD
RBC
WBC
Platelets
Abnormal 
Cells
MCV
Pt. No
Age
Sex
Hb (gm/dl)
TC
ESR
Platelet Count (in Lakhs)
PCV
MCH
RBC Count(in Lakhs)
Recticulocite Count
Sr. LDH
LGI scopy
Sr. Ferritin
Sr. Electrophoresis
Blood Urea
Sr Creatine
Peripheral Smear
Bone Marrow
Stool Occult Blood
Motion Ova Cyst
UGI scopy
Others
MNA score
Nutritional Status
Ailments
Type of Anemia
84 85 86 87 88 89 90 91 92 93
78 66 70 65 68 71 66 65 81 76
M M M M M M M M F M
8.2 9.0 8.9 5.6 10.6 9.7 9.7 8.7 8.4 8.8
5400 6200 7200 4600 10300 6800 4700 27300 7200 6400
16 26 38 88 32 33 42 32 34 46
1.00 1.80 1.90 1.80 1.90 1.80 1.00 1.80 1.90 1.90
30 28 30 32 21 24 26 28 21 30
116 80 86 84 84 78 86 114 74 104
34 30 32 32 33 32 32 34 30 34
3 3 2.94 2.6 3.4 3 3.6 3.1 2.86 3.1
1 1 0.8 0.5 1 0.9 1 0.8 1 0.8
194 164 198 188 144 156 44 281 186 164
77 104 56 890 56 12 168 76 18 28
- - - - - - - - - -
26 88 28 30 34 28 20 26 18 22
1 4.5 1 1.2 1 1 0.7 0.9 0.7 0.8
Macro Hypo Micro Hypo
Micro Macro 
Hypo Normo Normo
Micro Macro 
Hypo Micro Hypo Normo Normo
Normo Normo 
Macro Micro Hypo Macro Hypo
Normal Normal Normal Normal Increased Normal Normal Increased Normal Normal
Adequate Adequate Adequate Adequate Adequate Adequate Decreased Adequate Adequate AdequateHypersegmen
ted 
Neutrophils Burr Cells
Hypersegmen
ted 
Neutrophils - - - - - - -
Erythyroid 
Hypertlasia - - - hypercellular hypocellular - Hypercellular - -
Neg Neg Neg Neg Neg Neg Neg Neg Neg Neg
Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil
Normal Normal Normal Normal Post GJ Gastritis Normal Normal Normal Normal Normal
- - - - Normal - - - - -
Folate 2ng/ml -
Sr Fe 36μg/dl, 
B12 134 -
Sr Fe 40μg/dl 
B12 158 Sr Fe 26μg/dl - - Sr Fe 36μg/dl B12 124
16.5 22.5 21.5 16 18 17.5 21 22.5 18.5 22
Malnourished At Risk At Risk Malnourished At Risk At Risk At Risk At Risk At Risk At Risk
Folate Deficiency CKD Nutritional Abd. TB Post GJ Nutritional PT Sequalae DCLD Nutritional B12 Deficiency
Megaloblastic Renal Disease Combined ACD Combined Iron Deficiency ACD ACD Iron Deficiency Megaloblastic
ABBREVATIONS
Hb : Hemoglobin
WHO : World Health Organization
NHANES III :  National Health and Nutrition Examination Survey
RBC : Red Blood Cell
MCV :  Mean Corpuscular Volume
MCH :  Mean Corpuscular Hemoglobin
EPO : Erythropoietin
MDS : Myelodysplastic  Syndrome
MNA : Mini Nutritional Assessment
PEM :  Protein Energy Malnutrition
CKD : Chronic  Kidney Disease
RD : Renal  Disease
ACD : Anemia of Chronic Diseases
MMSE : Mini Mental Status Examination
AML : Acute Myeloid Leukemia
UGI : Upper Gastrointestinal
